Parental Reports on Late Effects and Follow-Up Needs: A Single-Center Assessment of Childhood Cancer Survivorship Care in Kenya.

Susan Nyabate Mageto, Jesse P M Lemmen, Festus Muigai Njuguna, Nancy Midiwo, Sandra Cheptoo Langat, Terry Allan Vik, Gertjan J L Kaspers

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Non-randomised prospective clinical trial to improve follow-up adherence, survivorship knowledge and late effects documentation at a childhood cancer clinic in Western Kenya: a study protocol.BMJ open · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Susan Nyabate MagetoEmma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit, Pediatric Oncology, 1105 AZ Amsterdam, The Netherlands.ORCID 0009-0007-5036-1938

Jesse P M LemmenEmma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit, Pediatric Oncology, 1105 AZ Amsterdam, The Netherlands.

Festus Muigai NjugunaAcademic Model Providing Access to Healthcare (AMPATH), Moi Teaching and Referral Hospital, Eldoret 30100, Kenya.

Nancy MidiwoAcademic Model Providing Access to Healthcare (AMPATH), Moi Teaching and Referral Hospital, Eldoret 30100, Kenya.

Sandra Cheptoo LangatAcademic Model Providing Access to Healthcare (AMPATH), Moi Teaching and Referral Hospital, Eldoret 30100, Kenya.

Terry Allan VikDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0002-9883-0568

Gertjan J L KaspersEmma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit, Pediatric Oncology, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0001-7716-8475

Funding

AFAS Foundation, NL and World Child Cancer, NL N A

6 · The paper itself

Abstract

The WHO Global Initiative for Childhood Cancer will likely increase the number of childhood cancer survivors in resource-poor countries. This study explored survivorship care in Kenya through parental reports on late effects and the follow-up needs of childhood cancer survivors. Parents of Kenyan childhood cancer survivors (under 18 years old) who completed treatment for at least one year were interviewed using semi-structured questionnaires from 2021 to 2022. Parents of 54 survivors were interviewed. Survivors had solid tumors (52%) and hematological tumors (48%). Most (52%) received chemotherapy combined with either surgery or radiotherapy. Many survivors (72%) experienced symptoms according to their parents. The most prevalent symptoms were pain (37%), fatigue (26%), and ocular problems (26%). Eleven percent of parents observed limitations in the daily activities of the survivors. Parents of survivors with two or more symptoms were more likely to rate symptoms as moderate to severe (

Indexed as

Cancer SurvivorsNeoplasmsParentsSurvivorshipAdolescentAftercareChildChild, PreschoolFemaleFollow-Up StudiesHumansInfantKenyaMaleSurveys and Questionnaireschildhood cancerfollow-uplate effects

Identifiers

PMID40136366

DOI10.3390/curroncol32030162

PMCPMC11941395

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.